Northann Corp. Receives NYSE American Delisting Determination; Company Requests Oral Hearing

FORT LAWN, S.C. — August 24, 2026 — Northann Corp. (“Northann” or the “Company”) disclosed that on August 21, 2026 it received written notification from NYSE Regulation that the Company is not suitable for continued listing under Sections 1001, 1002(e), 1003 and 1007 of the NYSE American Company Guide, and that NYSE Regulation has determined to commence proceedings to delist the Company’s common stock from the NYSE American. Trading of the common stock was suspended effective immediately.

The Company expects its common stock to begin quotation on the OTC Markets under the symbol “NCLX.” The OTC Markets are significantly more limited than the NYSE American, and this quotation results in a less liquid market for existing and potential stockholders.

On August 28, 2026, the Company submitted a request for oral hearing and review of the NYSE Regulation’s determination to the Listings Qualifications Panel of the Committee for Review of the Board of Directors of the Exchange. The Company cannot predict the timing or outcome of the hearing.

See the Forms 8-K filed by the Company on August 24 and August 31, 2026, available on SEC EDGAR.